Y-90 放射性栓塞联合 PD-1 抑制剂作为肝细胞癌的新辅助治疗
2.2K 次观看
•
被引用 2 次
•
09:11 分钟
•
2024年5月24日
DOI :10.3791/66407-v
2024年5月24日
•2.2K 次观看
Qiang Li*1 , Xiaolan Wang*1,2 , Deju Li*1 , Yulong Liu*3 , Kangshou Liu1 , Junjie Liang1 , Jian Sun1 , Quan Jiang1 , Jiexing Li1 , Zhilong Liu1 , Jian Gong4 , Leyang Xiang1 , Zhidong Jia1 , Zhiwei Chen1 , Mingrong Cao1 , Yuchuan Jiang1,5
1Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, 2Dongpu Branch, The First Affiliated Hospital, Jinan University, 3Department of Vascular Intervention, The First Affiliated Hospital, Jinan University, 4Department of Nuclear Medicine, The First Affiliated Hospital, Jinan University, 5Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University
* These authors contributed equally
本研究展示了将钇-90经动脉放射栓塞（Y-90 TARE）与抗PD-1单克隆抗体联合应用于初始复发风险较高的肝细胞癌（HCC）患者，作为有效新辅助治疗策略的方法学潜力，该策略可最终实现肝切除术。本文重点阐述了该联合方案的安全性、可行性及其逐步操作流程。
Chapters in this video
0:00
Introduction
2:03
Combining Y-90 Trans-Arterial Radioembolization and PD-1 Inhibitor Therapy with Hepatectomy to Treat High-Risk Hepatocellular Carcinoma
8:15
Representative Results
Related Videos
版权所有 © 2026 MyJoVE Corporation。保留所有权利。